CDMO Live takes place at Rotterdam’s World Trade Center on May 7-8, 2025. It will bring together Europe’s top pharmaceutical outsourcing decision-makers, shining a spotlight on this rapidly growing ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading ...
The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.
AstraZeneca AZN stock has risen 8.6% in the past month, mainly due to mixed fourth-quarter results and a positive update from ...
A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...
In a Phase Ib trial, 71 percent of patients responded to zongertinib and lived a median six months before disease progression or death.
Since returning to office last month, U.S. President Donald Trump has initiated numerous tariffs and made even more frequent ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...
Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback